Share Prices & Company Research

Market News

02 Mar 2021 | 08:02

Croda pre-tax profits slip amid weak performance in personal care unit

(Sharecast News) - Speciality chemical company Croda said full-year adjusted pre-tax profits had slipped in 2020 due to a weak performance in its core personal care unit. Croda said adjusted pre-tax profits had dropped 6.7% to £300.6m, with 2.2% sales growth in the group's core business unit being partially offset by a narrowing in its return on sales from 24.7% to 23.0%.

Profits from Croda's life sciences unit rose 20.8%, while its personal care and performance technologies division registered declines of 16% and 22.2%, respectively.

"While continued Covid-19 restrictions make the near-term outlook for elements of our consumer care and performance technologies sectors difficult to predict, 2020 sales exit rates were encouraging with consumer and industrial end markets showing signs of recovery," said Croda.

Croda anticipates that its deal to supply additives for Pfizer's Covid-19 vaccine will help support future growth in its life sciences business.

Elsewhere, Croda has agreed to acquire the worldwide business activities of Alban Muller for a total consideration of €25.0m.

As of 0910 GMT, Croda shares were up 0.29% at 6,322.0p.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.